Dominic Walsh

Affiliations: 
Neurology Harvard Medical School - Brigham and Women's Hospital 
Google:
"Dominic Walsh"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mengel D, Janelidze S, Glynn RJ, et al. (2020) Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease. Annals of Neurology
Walsh DM, Selkoe DJ. (2020) Amyloid β-protein and beyond: the path forward in Alzheimer's disease. Current Opinion in Neurobiology. 61: 116-124
Mengel D, Liu W, Glynn RJ, et al. (2020) Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase. Alzheimer's Research & Therapy. 12: 27
Corbett GT, Wang Z, Hong W, et al. (2019) PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathologica
Cha DJ, Mengel D, Mustapic M, et al. (2019) miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer's Patients. Frontiers in Neuroscience. 13: 1208
Zott B, Simon MM, Hong W, et al. (2019) A vicious cycle of β amyloid-dependent neuronal hyperactivation. Science (New York, N.Y.). 365: 559-565
Yang T, Dang Y, Ostaszewski B, et al. (2019) Target Engagement in an Alzheimer Trial: Crenezumab Lowers Aβ Oligomers in CSF. Annals of Neurology
Brinkmalm G, Hong W, Wang Z, et al. (2019) Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain. Brain : a Journal of Neurology. 142: 1441-1457
Ondrejcak T, Hu NW, Qi Y, et al. (2019) Soluble tau aggregates inhibit synaptic long-term depression and amyloid β-facilitated LTD in vivo. Neurobiology of Disease
Mengel D, Hong W, Corbett GT, et al. (2018) PrP-grafted antibodies bind certain amyloid β-protein aggregates, but do not prevent toxicity. Brain Research
See more...